2372-2373 / 2437
•
H15 (Boswellia serrata): limited activity
•
Bevacizumab (Avastin): i.v. administration, expensive, not
approved for anti-edematous therapy
•
Corticorelin acetate: synthetic corticotropin-releasing factor
Can we avoid/replace steroids?